Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’

On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association

doi:10.1111/cen.14136

Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’

On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association

Immunology and Immunotherapy

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	266-267
Number of pages	2
Journal	Clinical Endocrinology
Volume	92
Issue number	3
DOIs	https://doi.org/10.1111/cen.14136
Publication status	Published - 1 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1111/cen.14136

Cite this

On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association (2020). Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’. Clinical Endocrinology, 92(3), 266-267. https://doi.org/10.1111/cen.14136

On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association. / Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’. In: Clinical Endocrinology. 2020 ; Vol. 92, No. 3. pp. 266-267.

@article{cf144f0adbd645b3b7109722fd7bfbe0,

title = "Joint statement from the Society for Endocrinology and the British Thyroid Association regarding {\textquoteleft}Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism{\textquoteright}",

author = "\{On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association\} and Taylor, \{Peter N.\} and Okosieme, \{Onyebuchi E.\} and Krishna Chatterjee and Kristien Boelaert",

year = "2020",

month = mar,

day = "1",

doi = "10.1111/cen.14136",

language = "English",

volume = "92",

pages = "266--267",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley",

number = "3",

}

On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association 2020, 'Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’', Clinical Endocrinology, vol. 92, no. 3, pp. 266-267. https://doi.org/10.1111/cen.14136

Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’. / On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association.
In: Clinical Endocrinology, Vol. 92, No. 3, 01.03.2020, p. 266-267.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’

AU - On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association

AU - Taylor, Peter N.

AU - Okosieme, Onyebuchi E.

AU - Chatterjee, Krishna

AU - Boelaert, Kristien

PY - 2020/3/1

Y1 - 2020/3/1

UR - https://www.scopus.com/pages/publications/85076932039

U2 - 10.1111/cen.14136

DO - 10.1111/cen.14136

M3 - Letter

C2 - 31788839

AN - SCOPUS:85076932039

SN - 0300-0664

VL - 92

SP - 266

EP - 267

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 3

ER -

On behalf of the Executive Committees of the Society for Endocrinology and the British Thyroid Association. Joint statement from the Society for Endocrinology and the British Thyroid Association regarding ‘Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism’. Clinical Endocrinology. 2020 Mar 1;92(3):266-267. doi: 10.1111/cen.14136